4DMedical Limited (ASX:4DX) Lodges Supplementary Prospectus
Offer Details
4DMedical Limited has lodged a supplementary prospectus with ASIC and ASX, modifying the Original Prospectus dated 25 March 2025. The Offers include New Options exercisable at $0.55 per share and Piggyback Options at $0.75 per share, tied to the FDA clearance of its CT:VQ technology.
Amendment to Offer Terms
The Board has amended the Offers so that eligible participants are deemed to have applied for their allocation of New Options automatically, eliminating the need for a separate Application Form unless opting out. Participants wishing to opt out can contact the Share Registry via email or phone.
Motley Fool contributor Abbie Stokes has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.